Brigade Enterprises Limited disclosed the outcomes of its Nomination and Remuneration Committee (NRC) meeting held on Wednesday, August 12, 2026. The meeting commenced at 5:45 PM and concluded at 7:05 PM.

Key Decisions and Allotments

The Committee approved the following actions:

  • Allotment of 33,720 equity shares under the Brigade Employee Stock Option Plan, 2017
  • Allotment of 63,183 equity shares under the new Brigade Employee Stock Option Plan rolled out in 2022
  • Issue of 82,628 stock options under the Employee Stock Option Plan rolled out in 2022

Capital Structure Impact

The paid-up share capital of the Company increased from ₹326,162,380 to ₹326,259,283 (approximately ₹326.16 crore to ₹326.26 crore) due to the aforementioned allotment of equity shares.

Regulatory Disclosure Requirements

The disclosure is made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024.

ESOP Scheme Details

Grant Details: 82,628 stock options granted to eligible employees of the Group under the 'Brigade Employee Stock Option Plan'.

Regulatory Compliance: The scheme is in accordance with Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations 2021.

Share Coverage: Total of 82,628 equity shares covered by these options (each option eligible for 1 equity share of ₹10 each).

Pricing: Exercise price set at ₹296.25 per share in accordance with SEBI regulations.

Exercise Period: Options may be exercised within five years from the date of vesting of each tranche based on performance criteria being met.

Plan Approval: The 'Brigade Employee Stock Option Plan' was submitted to stock exchanges at the time of obtaining in-principle approval and received shareholder approval through a special resolution passed via Postal Ballot on May 4, 2022.

Current Status: Options have not yet vested, been exercised, lapsed, or undergone any variations. Subsequent changes, cancellations, or exercises are not applicable at this stage. Diluted earnings per share impact is not disclosed.